Report Detail

Pharma & Healthcare Global Ketorolac Tromethamine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2776826
  • |
  • 17 January, 2019
  • |
  • Global
  • |
  • 139 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.

Scope of the Report:
The worldwide market for Ketorolac Tromethamine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Ketorolac Tromethamine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Pfizer
Omeros Corporation
Egalet US Inc.
Allergan
Dr. Reddy’s Laboratories
Teva
Mylan
West Ward Pharmaceuticals
Fresenius Kabi
Apotex
Sandoz
Amphastar Pharmaceuticals
Gland Pharma Limited
Akorn
Sun Pharmaceutical
Sagent Pharmaceuticals
Aurobindo Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Injection
Ophthalmic
Nasal
Oral tablet

Market Segment by Applications, can be divided into
Short-term treatment of pain
Ophthalmic Surgery

There are 15 Chapters to deeply display the global Ketorolac Tromethamine market.
Chapter 1, to describe Ketorolac Tromethamine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Ketorolac Tromethamine, with sales, revenue, and price of Ketorolac Tromethamine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Ketorolac Tromethamine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Ketorolac Tromethamine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Ketorolac Tromethamine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

    1 Market Overview

    • 1.1 Ketorolac Tromethamine Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Injection
      • 1.2.2 Ophthalmic
      • 1.2.3 Nasal
      • 1.2.4 Oral tablet
    • 1.3 Market Analysis by Applications
      • 1.3.1 Short-term treatment of pain
      • 1.3.2 Ophthalmic Surgery
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Pfizer
      • 2.1.1 Business Overview
      • 2.1.2 Ketorolac Tromethamine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Pfizer Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 Omeros Corporation
      • 2.2.1 Business Overview
      • 2.2.2 Ketorolac Tromethamine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 Egalet US Inc.
      • 2.3.1 Business Overview
      • 2.3.2 Ketorolac Tromethamine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4 Allergan
      • 2.4.1 Business Overview
      • 2.4.2 Ketorolac Tromethamine Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Allergan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5 Dr. Reddy’s Laboratories
      • 2.5.1 Business Overview
      • 2.5.2 Ketorolac Tromethamine Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6 Teva
      • 2.6.1 Business Overview
      • 2.6.2 Ketorolac Tromethamine Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Teva Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7 Mylan
      • 2.7.1 Business Overview
      • 2.7.2 Ketorolac Tromethamine Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Mylan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8 West Ward Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 Ketorolac Tromethamine Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9 Fresenius Kabi
      • 2.9.1 Business Overview
      • 2.9.2 Ketorolac Tromethamine Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Fresenius Kabi Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10 Apotex
      • 2.10.1 Business Overview
      • 2.10.2 Ketorolac Tromethamine Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Apotex Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.11 Sandoz
      • 2.11.1 Business Overview
      • 2.11.2 Ketorolac Tromethamine Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Sandoz Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.12 Amphastar Pharmaceuticals
      • 2.12.1 Business Overview
      • 2.12.2 Ketorolac Tromethamine Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.13 Gland Pharma Limited
      • 2.13.1 Business Overview
      • 2.13.2 Ketorolac Tromethamine Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.14 Akorn
      • 2.14.1 Business Overview
      • 2.14.2 Ketorolac Tromethamine Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Akorn Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.15 Sun Pharmaceutical
      • 2.15.1 Business Overview
      • 2.15.2 Ketorolac Tromethamine Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.16 Sagent Pharmaceuticals
      • 2.16.1 Business Overview
      • 2.16.2 Ketorolac Tromethamine Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.17 Aurobindo Pharma
      • 2.17.1 Business Overview
      • 2.17.2 Ketorolac Tromethamine Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Ketorolac Tromethamine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Ketorolac Tromethamine Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Ketorolac Tromethamine Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Ketorolac Tromethamine Manufacturer Market Share in 2017
      • 3.3.2 Top 6 Ketorolac Tromethamine Manufacturer Market Share in 2017
    • 3.4 Market Competition Trend

    4 Global Ketorolac Tromethamine Market Analysis by Regions

    • 4.1 Global Ketorolac Tromethamine Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Ketorolac Tromethamine Sales and Market Share by Regions (2013-2018)
      • 4.1.2 Global Ketorolac Tromethamine Revenue and Market Share by Regions (2013-2018)
    • 4.2 North America Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 4.3 Europe Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 4.5 South America Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Ketorolac Tromethamine Sales and Growth Rate (2013-2018)

    5 North America Ketorolac Tromethamine by Countries

    • 5.1 North America Ketorolac Tromethamine Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Ketorolac Tromethamine Sales and Market Share by Countries (2013-2018)
      • 5.1.2 North America Ketorolac Tromethamine Revenue and Market Share by Countries (2013-2018)
    • 5.2 United States Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 5.3 Canada Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 5.4 Mexico Ketorolac Tromethamine Sales and Growth Rate (2013-2018)

    6 Europe Ketorolac Tromethamine by Countries

    • 6.1 Europe Ketorolac Tromethamine Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Ketorolac Tromethamine Sales and Market Share by Countries (2013-2018)
      • 6.1.2 Europe Ketorolac Tromethamine Revenue and Market Share by Countries (2013-2018)
    • 6.2 Germany Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 6.3 UK Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 6.4 France Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 6.5 Russia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 6.6 Italy Ketorolac Tromethamine Sales and Growth Rate (2013-2018)

    7 Asia-Pacific Ketorolac Tromethamine by Countries

    • 7.1 Asia-Pacific Ketorolac Tromethamine Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Ketorolac Tromethamine Sales and Market Share by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Ketorolac Tromethamine Revenue and Market Share by Countries (2013-2018)
    • 7.2 China Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 7.3 Japan Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 7.4 Korea Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 7.5 India Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 7.6 Southeast Asia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)

    8 South America Ketorolac Tromethamine by Countries

    • 8.1 South America Ketorolac Tromethamine Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Ketorolac Tromethamine Sales and Market Share by Countries (2013-2018)
      • 8.1.2 South America Ketorolac Tromethamine Revenue and Market Share by Countries (2013-2018)
    • 8.2 Brazil Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 8.3 Argentina Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 8.4 Colombia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)

    9 Middle East and Africa Ketorolac Tromethamine by Countries

    • 9.1 Middle East and Africa Ketorolac Tromethamine Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Ketorolac Tromethamine Sales and Market Share by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Ketorolac Tromethamine Revenue and Market Share by Countries (2013-2018)
    • 9.2 Saudi Arabia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 9.3 UAE Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 9.4 Egypt Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 9.5 Nigeria Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
    • 9.6 South Africa Ketorolac Tromethamine Sales and Growth Rate (2013-2018)

    10 Global Ketorolac Tromethamine Market Segment by Type

    • 10.1 Global Ketorolac Tromethamine Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Ketorolac Tromethamine Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Ketorolac Tromethamine Revenue and Market Share by Type (2013-2018)
    • 10.2 Injection Sales Growth and Price
      • 10.2.1 Global Injection Sales Growth (2013-2018)
      • 10.2.2 Global Injection Price (2013-2018)
    • 10.3 Ophthalmic Sales Growth and Price
      • 10.3.1 Global Ophthalmic Sales Growth (2013-2018)
      • 10.3.2 Global Ophthalmic Price (2013-2018)
    • 10.4 Nasal Sales Growth and Price
      • 10.4.1 Global Nasal Sales Growth (2013-2018)
      • 10.4.2 Global Nasal Price (2013-2018)
    • 10.5 Oral tablet Sales Growth and Price
      • 10.5.1 Global Oral tablet Sales Growth (2013-2018)
      • 10.5.2 Global Oral tablet Price (2013-2018)

    11 Global Ketorolac Tromethamine Market Segment by Application

    • 11.1 Global Ketorolac Tromethamine Sales Market Share by Application (2013-2018)
    • 11.2 Short-term treatment of pain Sales Growth (2013-2018)
    • 11.3 Ophthalmic Surgery Sales Growth (2013-2018)

    12 Ketorolac Tromethamine Market Forecast (2018-2023)

    • 12.1 Global Ketorolac Tromethamine Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Ketorolac Tromethamine Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Ketorolac Tromethamine Market Forecast (2018-2023)
      • 12.2.2 Europe Ketorolac Tromethamine Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Ketorolac Tromethamine Market Forecast (2018-2023)
      • 12.2.4 South America Ketorolac Tromethamine Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Ketorolac Tromethamine Market Forecast (2018-2023)
    • 12.3 Ketorolac Tromethamine Market Forecast by Type (2018-2023)
      • 12.3.1 Global Ketorolac Tromethamine Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Ketorolac Tromethamine Market Share Forecast by Type (2018-2023)
    • 12.4 Ketorolac Tromethamine Market Forecast by Application (2018-2023)
      • 12.4.1 Global Ketorolac Tromethamine Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Ketorolac Tromethamine Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Ketorolac Tromethamine . Industry analysis & Market Report on Ketorolac Tromethamine is a syndicated market report, published as Global Ketorolac Tromethamine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Ketorolac Tromethamine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,780.52
      4,170.78
      5,561.04
      3,246.84
      4,870.26
      6,493.68
      541,314.00
      811,971.00
      1,082,628.00
      289,988.40
      434,982.60
      579,976.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report